Search results for "JIA"

showing 10 items of 67 documents

Chi Zijian: Puolikuu

2022

Kirja-arvostelu teoksesta Chi, Z. & Sainio, R. k. (2022). Puolikuu. Aula & Co. nonPeerReviewed

Chi Zijiankirja-arvostelutPuolikuu
researchProduct

Traduzioni dal cinese in italiano di poesie

2018

Su richiesta dell'Editore della rivista "Zuopin", ho tradotto dal cinese all'italiano le poesie di 24 poeti lavoratori. L'elenco degli Autori e delle poesie tradotte è il seguente: Yang Ke: "Popolo", "Canton", "Attraversare" Zheng Xiaoqiong: "Officina", "Testimoniare", Hu Zhimin", "Yan Fen" Xie Xiangnan: "Camminare lungo la linea fra città e campagna", "Numeri", "Nella città di Xili", "Masticare canna da zucchero", "Respirare" Fang Zhou: "Ragazze che producono scarpe", "Una farfalla della zona industriale", "Il poeta nella stanza in affitto" Guo Jinniu: "Distratto in una fabbrica di mobili", " 'Il Capitale', attraverso aria, acqua e cibo, penetra nel corpo umano", "Via della magnolia Yulan"…

Contemporary Chinese poetry Chinese migrant poets Yang Ke Zheng Xiaoqiong Xie Xiangnan Fang Zhou Guo Jinniu Xu Lizhi Liu Dongwu Cheng Peng Xu Qiang Peng Zhengwu Zhang Shougang Luo Deyuan Xu Fei He Zhenzong Li Changkong Liu Lihua Sun Haitao Chi Moshu Jiang Ming Huang Jiwen Liu Hongxi Wu Xia Zhou Qizao A Lu.Poesia cinese contemporanea poeti cinesi migranti Yang Ke Zheng Xiaoqiong Xie Xiangnan Fang Zhou Guo Jinniu Xu Lizhi Liu Dongwu Cheng Peng Xu Qiang Peng Zhengwu Zhang Shougang Luo Deyuan Xu Fei He Zhenzong Li Changkong Liu Lihua Sun Haitao Chi Moshu Jiang Ming Huang Jiwen Liu Hongxi Wu Xia Zhou Qizao A Lu.Settore L-OR/21 - Lingue E Letterature Della Cina E Dell'Asia Sud-Orientale
researchProduct

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review

2020

Abstract Background Tocilizumab is an IL-6 receptor-blocking agent proposed for the treatment of severe COVID-19. The aim of this systematic review was to describe the rationale for the use of tocilizumab for the treatment of COVID-19 and to summarize the available evidence regarding its efficacy and safety. Methods MEDLINE, PubMed, EMBASE, pre-print repositories (bioRxiv and medRxiv) and two trial Registries were searched for studies on the use of tocilizumab in COVID-19 or SARS-CoV-2 infection, viral pneumonia, and/or sepsis until 20th June 2020. Results We identified 3 indirect pre-clinical studies and 28 clinical studies including 5776 patients with COVID-19 (13 with a comparison group,…

Coronavirus COVID-19 Pneumonia SARS-CoV-2 TocilizumabGCA Giant cell arteritispJIA Pediatric juvenile idiopathic arthritislaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawMedicine030212 general & internal medicineClinical efficacyCPAP Continuous positive airway pressureCOVID-19 Coronavirus disease 2019IDSA Infectious Diseases Society of AmericaRA Rheumatoid arthritisTocilizumabIMV Invasive mechanical ventilationsJIA Juvenile idiopathic arthritisAIFA Agenzia Italiana del FarmacoPulmonary and Respiratory Medicinemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEAntibodies Monoclonal HumanizedNIH U.S. National Institutes of HealthArticleWHO World Health OrganizationSIMIT Italian Society of Infectious and Tropical disease03 medical and health sciencesTocilizumabARDS Acute respiratory distress syndromeAnimalsHumansIn patientIntensive care medicineTocilizumab ; COVID-19 ; Pneumonia ; SARS-CoV-2 ; Coronaviruslcsh:RC705-779business.industryCRS CAR-T cell-induced cytokine release syndromeInterleukin-6SARS-CoV-2NIV Noninvasive mechanical ventilationTNF Tumor necrosis factorCOVID-19Pneumonialcsh:Diseases of the respiratory systemCOVID-19 Drug TreatmentClinical trialCoronavirus030228 respiratory systemchemistrybusinessICTRP International Clinical Trials Registry PlatformPulmonology
researchProduct

Crossfit lajianalyysi ja harjoittelu

2014

Lajin ominaispiirteet. CrossFitissä pyritään kehittämään urheilijan suorituskykyä mahdollisimman monipuolisesti välttäen erikoistumista. Urheilijan tavoitteena on kehittyä kaikissa seuraavista osa-alueista: 1) hengitys- ja verenkiertoelimistön kestävyys, 2) kestovoima, 3) maksimivoima, 4) nopeusvoima, 5) nopeus, 6) liikkuvuus, 7) koordinaatio, 8) ketteryys, 9) tasapaino ja 10) tarkkuus. Kilpailusuoritukset sisältävät monipuolisesti elementtejä eri lajeista, kuten juoksusta, uinnista soudusta, voimistelusta ja painonnostosta. Oleellinen osa CrossFit-harjoittelua ovat erilaiset WOD-harjoituskokonaisuudet (Workout of the Day), joita käytetään myös niin kutsuttuina Benchmark-harjoitteina. Bench…

CrossFitharjoittelun ohjelmointilajianalyysikilpailusäännöt
researchProduct

Síndrome de Horner como manifestación de disección carotídea

2011

Caso Clínico: Un varón de 42 años se presenta con ptosis y miosis izquierda después de una historia de cefalea homolateral de 20 días de evolución, que empeora progresivamente durante los últimos días. Una angioresonancia revela disección de la arteria carótida interna. Discusión: El «síndrome de Horner doloroso» destaca como una urgencia médica por posible manifestación de una disección carotídea. Consideramos que el perfecto conocimiento de las urgencias neurooftalmológicas es de gran necesidad para el médico oftalmólogo y que estas requieren una atención multidisciplinaria para asegurar un seguimiento y tratamiento adecuado. Clinical Case: A 42-year-old man presented with ptosis and mios…

Disección arteria carótida interna/diagnósticoMiosismedicine.medical_specialtygenetic structuresOftalmoplejia simpáticaCarotid Artery Internal Dissection/diagnosisHorner syndromeDissection (medical)Carotid artery dissectionSympathetic Ocular-OphthalmoplegiaPtosisSíndrome de Horner/fisiopatologíamedicine.arterymedicineInternal carotid artery dissectionbusiness.industryGeneral Medicinemedicine.diseaseeye diseasesHeadache/aetiologySurgeryDisección arteria carótida interna/complicacionesLeft eyeCarotid Artery Internal Dissection/complicationsCefalea/etiologíamedicine.symptomInternal carotid arterybusinessHorner Syndrome/pathophysiologyArchivos de la Sociedad Española de Oftalmología (English Edition)
researchProduct

Síndrome de Horner como manifestación de disección carotídea

2011

Resumen Caso Clinico Un varon de 42 anos se presenta con ptosis y miosis izquierda despues de una historia de cefalea homolateral de 20 dias de evolucion, que empeora progresivamente durante los ultimos dias. Una angioresonancia revela diseccion de la arteria carotida interna. Discusion El «sindrome de Horner doloroso» destaca como una urgencia medica por posible manifestacion de una diseccion carotidea. Consideramos que el perfecto conocimiento de las urgencias neurooftalmologicas es de gran necesidad para el medico oftalmologo y que estas requieren una atencion multidisciplinaria para asegurar un seguimiento y tratamiento adecuado.

Disección arteria carótida interna/diagnósticoOphthalmologyDisección arteria carótida interna/complicacionesOftalmoplejia simpáticaSíndrome de Horner/fisiopatologíaCefalea/etiología
researchProduct

A more distinctive representation for 3D shape descriptors using principal component analysis

2015

Many researchers have used the Heat Kernel Signature (or HKS) for characterizing points on non-rigid three-dimensional shapes and Classical Multidimensional Scaling (Classical MDS) method in object classification which we quote, in particular, the example of Jian Sun et al. (2009) [1]. However, in this paper, the main focuses on classification that we propose a concise and provably factorial method by invoking Principal Component Analysis (PCA) as a classifier to improve the scheme of 3D shape classification. To avoid losing or disordering information after extracting features from the mesh, PCA is used instead of the Classical MDS to discriminate-as much as possible-feature points for each…

Heat kernel signaturebusiness.industryPrincipal component analysisJianPattern recognitionMultidimensional scalingArtificial intelligencePrincipal geodesic analysisbusinessClassifier (UML)Kernel principal component analysisShape analysis (digital geometry)Mathematics2015 16th International Conference on Sciences and Techniques of Automatic Control and Computer Engineering (STA)
researchProduct

La capogruppo della cucina

2017

Traduzione dal cinese all'italiano

Jian JiaSettore L-OR/21 - Lingue E Letterature Della Cina E Dell'Asia Sud-Orientale
researchProduct

Il direttore di fabbrica Qiao assume il suo nuovo incarico

2017

Traduzione dal cinese all'italiano

Jiang ZilongSettore L-OR/21 - Lingue E Letterature Della Cina E Dell'Asia Sud-Orientale
researchProduct

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis : 6-year efficac…

2019

Background To describe the 6-year safety and efficacy of etanercept (ETN) in children with extended oligoarticular juvenile idiopathic arthritis (eoJIA), enthesitis-related arthritis (ERA), and psoriatic arthritis (PsA) Methods Patients who completed the 2-year, open-label, phase III CLinical Study In Pediatric Patients of Etanercept for Treatment of ERA, PsA, and Extended Oligoarthritis (CLIPPER) were allowed to enroll in its 8-year long-term extension (CLIPPER2). Children received ETN at a once-weekly dose of 0.8 mg/kg, up to a maximum dose of 50 mg/week. Efficacy assessments included the JIA core set of outcomes, the JIA American College of Rheumatology response criteria (JIA-ACR), and t…

Malelcsh:Diseases of the musculoskeletal systemArthritisCHILDRENCATEGORIESDISEASE-ACTIVITYEtanerceptEtanerceptEnthesitis-related arthritis (ERA)Juvenile Arthritis Disease Activity ScoreDOUBLE-BLINDINITIATIONNECROSIS-FACTORDEFINING CRITERIAMedicine and Health SciencesMedicineChildNon-U.S. Gov'tClinical trial; Efficacy; Enthesitis-related arthritis; Enthesitis-related arthritis (ERA); Etanercept; Extended oligoarticular juvenile idiopathic arthritis (eoJIA); Juvenile idiopathic arthritis; Psoriatic arthritis (PsA); SafetyOligoarthritisResearch Support Non-U.S. Gov'tMETHOTREXATEClinical trialTreatment OutcomeAntirheumatic AgentsChild PreschoolFemaleSafetymedicine.drugResearch Articlemedicine.medical_specialtyAdolescentEfficacyEnthesitis-related arthritisResearch SupportPsoriatic arthritisPsoriatic arthritis (PsA)Internal medicineAdalimumabJournal ArticleHumansetanercept ; juvenile idiopathic arthritis ; enthesitis-related arthritis ; extended oligoarticular juvenile idiopathic arthritis (eoJIA) ; enthesitis-related arthritis (ERA) ; psoriatic arthritis (PsA) ; efficacy ; safety ; clinical trialPEDIATRIC-PATIENTSbusiness.industryJuvenile idiopathic arthritismedicine.diseaseRheumatologyArthritis JuvenileOligoarticular Juvenile Idiopathic Arthritislcsh:RC925-935Extended oligoarticular juvenile idiopathic arthritis (eoJIA)businessADALIMUMAB
researchProduct